Co-founder, Consultant expert on preclinical and clinical development
Denis Ravel is the founder of Initial R&D Consulting, a consulting firm accompanying young biotechnology companies in preclinical and clinical development of small biopharmaceutical molecules. Engineer in Biology with a Ph.D. in Biochemistry from the University Pierre & Marie Curie (Paris, France), he has more than 25 years of experience in pharmaceutical R&D within large pharmaceutical laboratories or biotechnology companies (Servier, Genset-Merck-Serono, Diatos and more recently Neurochlore). He is currently responsible for the development of molecules and biomolecules in several therapeutic fields including cancer, neurodegenerative diseases, diabetes, AIDS and genetic diseases. He is also a member of the national commission “Diagnostic and therapeutic innovations; Epidemiology ; Prevention research” of the Association for Cancer Research.